测量人类脓毒症中的宿主抵抗、疾病耐受与损伤特征:一项前瞻性队列研究
该前瞻性队列研究纳入444例符合Sepsis-3标准的成人社区起病脓毒症患者,在急诊科到达后6小时内入组,采用SENECA方法进行临床亚型分型(α、β、γ、δ),并通过结构化专家排序与共识裁定将16种血浆和尿液生物标志物归入宿主抵抗、疾病耐受和宿主损伤三个机制轴。校正年龄、性别和种族后,宿主损伤特征越强与90天死亡率升高相关(aOR=1.70;95%CI 1.38-2.11;p<0.001),而宿主抵抗(aOR=0.83;95%CI 0.54-1.10;p=0.4)和疾病耐受(aOR=0.83;95%CI 0.68-1.01;p=0.06)与死亡率无显著关联。不同脓毒症亚型间差异在疾病耐受和损伤特征上最为明显,δ型患者损伤更高、疾病耐受更低,α型患者损伤更低、疾病耐受更高。
要点
- 在444例社区起病脓毒症成人中,校正年龄、性别和种族后,宿主损伤生物标志物特征与90天死亡率升高独立相关(aOR=1.70;95%CI 1.38-2.11;p<0.001)。
- 宿主抵抗特征与90天死亡率无显著关联(aOR=0.83;95%CI 0.54-1.10;p=0.4),疾病耐受特征与90天死亡率无显著关联(aOR=0.83;95%CI 0.68-1.01;p=0.06)。
- δ型脓毒症患者表现出更高的损伤特征和更低的疾病耐受特征,α型患者表现出更低的损伤特征和更高的疾病耐受特征。
- 研究在急诊科到达后6小时内入组符合Sepsis-3标准的成人,平均年龄60岁(SD:16),平均SOFA评分4.3(SD:2.3),90天死亡率为17%。
适用人群与场景
- 符合Sepsis-3标准的成人社区起病脓毒症患者,在急诊科到达后6小时内前瞻性入组。
- 平均年龄60岁(SD:16),平均SOFA评分4.3(SD:2.3)。
诊断标准与关键阈值
- 采用Sepsis-3标准诊断脓毒症。
- 采用SENECA方法将患者分为临床亚型(α、β、γ、δ)。
研究设计与关键结果
- 研究类型:前瞻性队列研究;样本量:444例成人;人群:社区起病脓毒症,急诊科到达后6小时内入组。
- 主要终点:90天死亡率17%。
- 校正年龄、性别和种族后,宿主损伤特征与90天死亡率升高相关(aOR=1.70;95%CI 1.38-2.11;p<0.001)。
- 宿主抵抗特征与90天死亡率无显著关联(aOR=0.83;95%CI 0.54-1.10;p=0.4)。
- 疾病耐受特征与90天死亡率无显著关联(aOR=0.83;95%CI 0.68-1.01;p=0.06)。
- 不同脓毒症亚型间差异在疾病耐受和损伤特征上最为明显:δ型患者损伤更高、疾病耐受更低,α型患者损伤更低、疾病耐受更高。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,由专家共识确定的与宿主抵抗、疾病耐受和宿主损伤对齐的生物标志物特征与临床结局和脓毒症亚型归属相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To understand how protein biomarkers in blood and urine that are aligned with host resistance to infection, disease tolerance, and damage are associated with clinical outcomes and sepsis subtypes in community-onset sepsis.
METHODS: Adults meeting Sepsis-3 criteria were prospectively enrolled within 6 h of emergency department arrival and assigned clinical subtypes (α, β, γ, δ), using the Sepsis ENdotyping in Emergency CAre (SENECA) approach. Using structured expert ranking with consensus adjudication, 16 plasma and urinary biomarkers obtained from remnant biospecimens were grouped into three mechanistic axes contributing to sepsis pathophysiology: host resistance to infection, disease tolerance, and damage to the host. Biomarkers for each concept were analyzed with principal component analysis as a signature, and multivariable logistic regression tested associations of each signature with 90-day mortality and sepsis subtype membership.
RESULTS: Among 444 adults, the mean age was 60 years [SD: 16], the mean SOFA score was 4.3 [SD: 2.3], and 90-day mortality was 17%. After adjustment for age, sex, and race, greater damage to the host was associated with increased 90-day mortality (adjusted odds ratio (aOR) = 1.70; 95% CI 1.38-2.11; p < 0.001), while greater host resistance (aOR = 0.83; 95% CI 0.54-1.10; p = 0.4) and greater disease tolerance (aOR = 0.83; 95% CI 0.68-1.01; p = 0.06) were not. Differences across sepsis subtypes were most pronounced for disease tolerance and damage signatures, where the δ‑type patients exhibited higher damage and lower disease tolerance and the α‑type patients had lower damage and higher disease tolerance.
CONCLUSION: Biomarker signatures aligned with host resistance to infection, disease tolerance, and damage to the host, informed by expert consensus, were associated with clinical outcomes and sepsis subtype membership.
参考来源
- Chowdhury A, Powell RE, Kennedy JN, et al. Measuring signatures of host resistance, disease tolerance, and damage in human sepsis: a prospective cohort study. Intensive Care Med. 2026. PMID: 41944864. doi:10.1007/s00134-026-08404-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。